Publications by authors named "Shi-Hao Qi"
Article Synopsis
- Post-viral olfactory dysfunction (PVOD) is a common symptom of long COVID that lacks effective treatments, prompting a systematic review of traditional Chinese medicine (TCM) for potential solutions.
- The review included various studies evaluating TCM, specifically acupuncture and acupoint injection, which demonstrated some effectiveness for PVOD, although the overall quality of evidence was deemed low.
- While some trials showed positive outcomes, more rigorous and well-designed studies are necessary to confirm the effectiveness and safety of acupuncture and acupoint injection in treating PVOD.
Objective: To assess the benefit and harm of Chinese medicine Xianling Gubao (XLGB) capsule compared to conventional medication or placebo to inform clinical practice.
Methods: We included randomized controlled trials (RCTs) with Jadad score ≥3 of XLGB capsule compared to pharmaceutical medication, placebo, or no treatment for primary osteoporosis. We conducted searches in EMBASE, Cochrane CENTRAL, MEDLINE, China National Knowledge Infrastructure, VIP, Wanfang, and Chinese Biomedical Literature Database (Sino-Med) from their inception till November 13, 2021.